Veradermics (MANE) Total Current Liabilities (2024 - 2026)

Veradermics' Total Current Liabilities history runs 3 years deep, the most recent figure standing at $6.7 million for Q1 2026.

• Quarterly Total Current Liabilities changed N/A year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (changed N/A YoY) and the FY2025 annual result came in at $9.2 million, up 93.98% from the prior year.
• Total Current Liabilities was $6.7 million for Q1 2026 at Veradermics, down from $9.2 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $9.2 million in Q4 2025 and bottomed at $4.7 million in Q4 2024.
• A 3-year average of $6.9 million and a median of $6.7 million in 2026 frame the typical range for Total Current Liabilities.
• Peak annual rise in Total Current Liabilities reached 93.98% in 2025, while the deepest fall reached 93.98% in 2025.
• Veradermics' Total Current Liabilities stood at $4.7 million in 2024, then jumped by 93.98% to $9.2 million in 2025, then retreated by 26.62% to $6.7 million in 2026.
• Business Quant data shows MANE's Total Current Liabilities at $6.7 million in Q1 2026, $9.2 million in Q4 2025, and $4.7 million in Q4 2024.